With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia ...

GSK’s ViiV Healthcare and its bimonthly pre-exposure prophylaxis (PrEP) medicine Apretude had to make room for another ...

The role puts Trépanier at the helm of Publicis Health Media’s (PHM’s) healthcare professional-focused practice and tasks him ...

Codis, born from the fusion of U.S.-based Particle Dynamics and a U.K. | In addition to substantial spray drying capacity, ...

Brexafemme (ibrexafungerp) partners GSK and Scynexis have worked out their quarrel related to a clinical trial that was previously put on hold, leaving Scynexis with a $22 million payout. | Through ...

Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. | Halozyme scoured very broadly for ...

Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about ...

With two Trump administration drug pricing deals in the books and more likely on the way, the U.S. policy environment could ...

It appears problems at Novo Nordisk’s recently acquired manufacturing facility in Indiana aren’t going to be solved any time ...

State privacy laws are reshaping the way pharmaceutical companies reach patients, said Katie Carr, chief revenue officer at ...